Literature DB >> 24065625

Diabetes mellitus and aortic aneurysm rupture: a favorable association?

Nada Selva Theivacumar1, Matthew A Stephenson, Hiren Mistry, Domenico Valenti.   

Abstract

INTRODUCTION: Recent reports suggest that diabetic patients are relatively unlikely to have abdominal aortic aneurysms (AAAs). This retrospective study assesses the relationship between diabetes mellitus (DM) and aortic aneurysm rupture.
METHODS: Patients with a diagnosis of any aortic aneurysm during a 10-year period were identified from our records. Patients with diagnoses of aortic aneurysm (thoracic, thoracoabdominal, and abdominal, treated and untreated) were included. Patients with nonatheromatous aneurysms (transection, dissection, mycotic, or isolated iliac) were excluded.
RESULTS: In all, 1830 patients with nonruptured aneurysms and 232 ruptured aneurysms were included giving a total of 2062 patients with aortic aneurysms (abdominal, thoracic, and thoracoabdominal). Of these 1830, 225 (12.3%) patients with nonruptured aneurysm were diabetic; however, only 13 (5.6%) of the 232 patients with ruptured aortic aneurysm were diabetic (odds ratio [OR] = 0.42; confidence interval [CI]: 0.23-0.75, P = .004). Considering only those with AAAs, 184 (12.4%) of the 1482 nonruptured AAA were diabetic; however, only 12 (6.4%) of the 188 patients with ruptured AAA were diabetic (OR = 0.48 [CI: 0.26-0.88], P = .02). In this study group, the odds of dying due to aneurysm rupture in the diabetic group are significantly lower compared to the nondiabetic groups (OR = 0.31 [CI: 0.13-0.69], P = .004), despite the finding that diabetic patients had almost the same life expectancy as nondiabetic patients (DM, 73 years [67-80] vs non-DM, 75 years [68-82] P = .23).
CONCLUSIONS: Diabetic patients with aortic aneurysms are significantly less likely to present with rupture or to die from aneurysm rupture when compared to nondiabetic patients with aortic aneurysms. We have identified association only, not causality. However, it is plausible that DM, or the treatment of DM, may have a protective effect on aortic aneurysm rupture.

Entities:  

Keywords:  aortic aneurysm; diabetes; ruptured AAA

Mesh:

Year:  2013        PMID: 24065625     DOI: 10.1177/1538574413505921

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  6 in total

Review 1.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

2.  Investigating the inverse association between glycaemia and abdominal aortic dilatation in a large Chinese hypertensive population: a cross-sectional study.

Authors:  Simeng Zhang; Jie Liu; Xin Jia; Tao Zhang; Xianhui Qin; Senhao Jia; Yue Li; Lishun Liu; Yuxiang Song; Shangwei Zuo; Ren Wei; Chen Duan; Zhongyin Wu; Yangyang Ge; Xian Wang; Wei Kong; Xiping Xu; Qiang Wang; Yong Huo; Wei Guo
Journal:  Ann Transl Med       Date:  2022-04

3.  Association Between Metformin and Abdominal Aortic Aneurysm: A Meta-Analysis.

Authors:  Wenqiang Niu; Juan Shao; Benxiang Yu; Guolong Liu; Ran Wang; Hengyang Dong; Haijie Che; Lubin Li
Journal:  Front Cardiovasc Med       Date:  2022-05-23

4.  Autonomic remodeling may be responsible for decreased incidence of aortic dissection in STZ-induced diabetic rats via down-regulation of matrix metalloprotease 2.

Authors:  Rui Hu; Zhiwei Wang; Zongli Ren; Min Liu
Journal:  BMC Cardiovasc Disord       Date:  2016-10-21       Impact factor: 2.298

5.  Age-dependent differences in the prognostic relevance of body composition-related variables in type A aortic dissection patients.

Authors:  Zeng-Rong Luo; Xiao-Dong Chen; Liang-Wan Chen
Journal:  J Cardiothorac Surg       Date:  2021-12-28       Impact factor: 1.637

6.  Hyperglycemia Suppresses Calcium Phosphate-Induced Aneurysm Formation Through Inhibition of Macrophage Activation.

Authors:  Teruyoshi Tanaka; Yuichiro Takei; Dai Yamanouchi
Journal:  J Am Heart Assoc       Date:  2016-03-28       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.